ASTS Plunges as SpaceX IPO Rewrites Satellite Pecking Order

AST SpaceMobile shares fell 15.5% the day SpaceX went public, with initial losses hitting 20% as the market made a calculation that took roughly ninety seconds: SpaceX wins, ASTS does not. The numbers that triggered the selloff were not subtle. SpaceX priced its IPO at $135 per share, raising $75 billion and landing a $1.8 trillion valuation. The market has now seen what AST is competing against, and the market is not impressed with AST's odds.

AST hit a 2026 low on the back of this shift, as investors recalibrated what satellite-broadband dominance actually looks like when a $1.8 trillion company with proven profitability controls the primary asset. Alphabet, which held a 25% stake in ASTS—making it the fourth-largest investor—now faces a portfolio rebalancing question that answers itself. A 25% position in a struggling satellite play becomes awkward when you can own equity in a $1.8 trillion company that already prints profit. Alphabet's stake could shrink to less than 1% of its portfolio following the SpaceX debut. The market has seen this script before: when competitive ambiguity dies, capital flees to the certain winner.

The timing is instructive because AST was not without tailwinds before Thursday. The company had secured over $1.2 billion in contracted revenue commitments with partners. It had planned a launch of three next-generation BlueBird satellites for June 17. It had positioned itself as the most prominent listed pure-play in direct-to-device satellite broadband. None of it mattered because SpaceX showed up with a playbook that reads like this: be profitable, deploy faster, and control ten times the orbital real estate.

SpaceX plans to expand its Starlink constellation to 42,000 satellites. AST plans to deploy 45 to 60 satellites by the end of 2026. The asymmetry is not a competitive feature or a scalability question. It is a market definition. SpaceX is not competing in AST's market. SpaceX is the market.

Asset managers who had bet on AST as a hedge against SpaceX dominance now own equity in SpaceX. Barclays cut its price target on ASTS to $60 from $65, implying 35% downside. That estimate was made after a Q1 earnings miss that marked the fifth consecutive EPS miss in five quarters—AST reported negative 66 cents per share versus expectations of negative 23 cents. The company was not firing on any cylinder. When bad momentum meets better alternatives, bad momentum loses.

Roth Capital argued that ASTS has a "better mousetrap" and a two-year lead over Starlink on the direct-to-device model. The problem with being ahead on technology when the competitor behind you raises $75 billion and trades at $1.8 trillion is that the mousetrap becomes academic. SpaceX's regulatory approvals, launch cadence, and manufacturing scale—the unglamorous bits that actually matter—now have $75 billion and a valuation floor behind them. Two-year leads evaporate fast when the other player can spend that entire two years expanding infrastructure that was already ahead.

The satellite market is not broken. It is not irrational. It is functioning exactly as markets do when a third alternative crystallizes: ambiguity dies, capital reallocates, and investors stop hedging bets. SpaceX was always going to win this narrative. The market just needed to see the price tag to make it official.